All News Medesis Pharma S.A.

Equities

ALMDP

FR0010844464

Market Closed - Euronext Paris Other stock markets 15:18:19 28/06/2024 BST			5-day change	1st Jan Change
0.83 ^EUR	-0.95%		-9.59%	-4.38%

06-05	MEDESIS : Invest Securities confirms its 'neutral' rating	CF
2023	Medesis Pharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

MEDESIS : Invest Securities confirms its 'neutral' rating	06-05	CF
MEDESIS PHARMA : Obtention d’un financement pour poursuivre l'analyse des résultats de la première phase d'essais cliniques de phase 2 pour le traitement de la maladie d’Alzheimer	06-03	PU
Medesis Pharma S A : Termination of the agreement between NICE and GREEN S.A. and Medesis Pharma	03-19	PU
Medesis Pharma : Résiliation du contrat avec la société NICE & GREEN S.A.	03-19	PU
MEDESIS PHARMA : Apport en trésorerie	12-20	PU
Medesis Pharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	27/10/23	CI
Medesis Pharma S A : END OF ENROLLEMENT OF THE 68 PATIENTS IN MEDESIS PHARMA PHASE 2 CLINICAL STUDY OF NANOLITHIUM FOR THE TREATMENT OF ALZHEIMER’S DISEASE	17/10/23	PU
MEDESIS : Invest Securities confirms its recommendation	06/10/23	CF
Medesis Pharma: selected for the Prix Galien USA	04/08/23	CF
MEDESIS : Invest Securities maintains its recommendation	12/07/23	CF
MEDESIS : Invest Securities confirms its recommendation	07/07/23	CF
Global markets live: Gamestop, Lucid, Meta Platforms, Vodafone, Nestlé...	08/06/23
MEDESIS PHARMA: FAVORABLE REPORT FROM IDSMB EXPERTS ON THE ONGOING PHASE 2 CLINICAL STUDY ON NANOLITHIUM IN THE TREATMENT OF ALZHEIMER'S DISEASE	23/05/23	PU
Global markets live: Shell, Netflix, Nike, Ocado, Tesla...	31/03/23
Medesis Pharma S A : MET EN PLACE UN FINANCEMENT OBLIGATAIRE D’UN MONTANT NOMINAL MAXIMUM POTENTIEL DE 2 500 000 EUROS	31/03/23	PU
Global markets live: Blackberry, Meta Platforms, Rivian, GM...	07/03/23
MEDESIS PHARMA : ENREGISTREMENT EN EURASIE DU BREVET DE PROTECTION DU CANDIDAT MEDICAMENT POUR LA DECORPORATION DU CESIUM	12/12/22	PU
Medesis Pharma S A : PRÉSENTE UN POSTER SCIENTIFIQUE À LA CONFÉRENCE CLINICAL TRIALS ON ALZHEIMER'S DISEASE DE SAN FRANCISCO	28/11/22	PU
Medesis Pharma S A : PRESENTS A SCIENTIFIC POSTER AT THE CLINICAL TRIALS ON ALZHEIMER'S DISEASE CONFERENCE IN SAN FRANCISCO	28/11/22	PU
Medesis Pharma S A : ANNONCE LA CRÉATION D’UN CONSEIL SCIENTIFIQUE PERMANENT D’EXPERTS EN MALADIES NEURODEGENERATIVES	21/11/22	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Medesis Pharma S.A.

Equities

ALMDP

FR0010844464

All News

Filters